jpm

Date:

Event description:

Meet with Novotech at JPM to discuss accelerated FIH pathways, smarter regional strategies, and global execution designed for biotech momentum.

What we offer biotechs: 

Move faster 

  • Start first-in-human (FIH) in Australia without an IND, using established regulatory pathways and experienced local teams.
  • Activate sites quickly in high-performing regions so you can reach decision-making data sooner and avoid slow-start bottlenecks. 

Spend smarter 

  • Tap capital-efficient regions across APAC and China, where startup, monitoring, and enrollment costs can be significantly lower than in traditional markets.
  • Structure studies to balance cost, speed, and quality, ensuring every dollar is focused on reaching your next milestone—not on unnecessary rerouting. 

Scale globally 

  • Integrate North America, Europe, and APAC under one coordinated operating model, with consistent governance and communication.
  • Benefit from transparent delivery and predictable timelines to support board, partner, and investor discussions. 

If your science is ready to move, we’re ready to help you move faster. 

Schedule a meeting with our team.

This event has concluded

Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.

Have a question or want to continue the conversation?

Talk to a Clinical Development Expert

Meet Our Team

Novotech

Dr. Judith Ng-Cashin

Novotech
Chief Medical Officer
Novotech

Barry Murphy

Novotech
Chief Commercial Officer
Novotech

Dr. Yooni Kim

Novotech
Chief Product Officer
Novotech

Michael Stibilj

Novotech
Chief Operating Officer
Novotech

Rick Farris

Novotech
Managing Director, North America
Novotech China

Andy Liu

Novotech China
Managing Director, Greater China & Global Labs Executive
Novotech

Dr. David Ng

Novotech
Vice President of Biometrics

Plus commercial and clinical teams from North America, Europe, and APAC.